Showing results (1-10 of 43) with videos related to
Sort By:
Pageof 5
Nederlands Tijdschrift Voor Geneeskunde|April 29, 1998
[Hormone replacement therapy following breast carcinoma]J G Klijn, M BontenbalClinical Breast Cancer|March 20, 2002
Capecitabine in breast cancer: current statusC H Smorenburg, M Bontenbal, J VerweijThe Netherlands Journal of Medicine|June 15, 2005
Clinical experience with venlafaxine in the treatment of hot flushes in women with a history of breast cancerA R van Gool, M Bannink, M Bontenbal, et al.European Journal of Cancer (Oxford, England : 1990)|November 27, 2001
Combination chemotherapy of the taxanes and antimetabolites: its use and limitationsC H Smorenburg, A Sparreboom, M Bontenbal, et al.Journal of Biological Regulators and Homeostatic Agents|September 24, 2005
An immunomagnetic epithelial tumor cell enrichment model for minimal residual disease detection of cytokeratin 8+ malignanciesR A Brooimans, N de Leeuw, M Bontenbal, et al.Cancer Treatment Reviews|April 1, 1993
Cell biological factors associated with the response of breast cancer to systemic treatmentJ G Klijn, E M Berns, M Bontenbal, et al.European Journal of Cancer & Clinical Oncology|September 1, 1988
Oestradiol enhances doxorubicin uptake and cytotoxicity in human breast cancer cells (MCF-7)M Bontenbal, P Sonneveld, J A Foekens, et al.Nederlands Tijdschrift Voor Geneeskunde|October 9, 1998
[Chemotherapy in metastasized breast carcinoma]M Bontenbal, R de Wit, J G Klijn, et al.Breast Cancer Research and Treatment|June 1, 1997
MRI in patients with axillary metastases of occult breast carcinomaM M Tilanus-Linthorst, A I Obdeijn, M Bontenbal, et al.Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Novel endocrine therapies in breast cancerJ G Klijn, B Setyono-Han, M Bontenbal, et al.Pageof 5